Officials at the Federal Trade Commission (FTC) say the 12- to 14-year patent-protection period given to biologic medications is too long to "promote innovation" in the development of these types of drugs. Biotechnology medicines (including such medications as Enbrel, Humira, and Remicade) are derived from living matter and can cost tens of thousands of dollars a year. Lawmakers would like to give the U.S. Food and Drug Administration (FDA) authority to clear cheaper copies of these drugs,...
Read moreI have long been a supporter of generic medications. They are not only less expensive for me but they are less expensive for insurance... Read more »
I had always been told that the active ingredients in generic medications had to be exactly the same as their brand name counterparts; that... Read more »
As women go through perimenopause and menopause, one of the emerging concerns is how to stop the loss of bone density. Experts are not sure... Read more »
Klonopin is an anti-anxiety drug that's often prescribed for anxiety accompanying bipolar disorder, panic disorder and some seizure... Read more »
It has long been thought that Cymbalta (generic name duloxetine) would be the second medication to receive FDA approval for the treatment... Read more »
Results from a long-term, large study suggest that expensive, brand-name blood pressure drugs are no better at preventing cardiovascular disease than... Read more »
Having diabetes is not for wimps. Most patients with the disease are aware of the long-term complications: the increased risk for heart disease,... Read more »
(Ivanhoe Newswire) -- The free samples you get from your doctor might be costing you more in the long run. Researchers who studied the use of free... Read more »